Trials / Conditions / Lung; Disease, Interstitial, With Fibrosis
Lung; Disease, Interstitial, With Fibrosis
7 registered clinical trials studyying Lung; Disease, Interstitial, With Fibrosis — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers NCT06482190 | Shenzhen Resproly Biopharmaceutical Co., Ltd | Phase 1 |
| Recruiting | Deep Learning Diagnostic and Risk-stratification for IPF and COPD NCT05318599 | Pediatric Clinical Research Platform | — |
| Completed | Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID NCT06383819 | NPO Petrovax | Phase 3 |
| Active Not Recruiting | Partitioned Training of Patients With Idiopathic Pulmonary Fibrosis NCT03752892 | West Park Healthcare Centre | N/A |
| Active Not Recruiting | BPF Genetics of ILD Study NCT03747627 | University of Dundee | — |
| Unknown | Basiliximab Treating Interstitial Pneumonia of CADM NCT03192657 | RenJi Hospital | Phase 2 |
| Completed | Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease NCT01781793 | University of British Columbia | N/A |